![1]() - News- IV drug users: The new face of candidemia- April 28, 2021- Intravenous drug use is an increasingly common risk factor for candidemia as the opioid crisis worsens. 
- News- Pfizer developing pill to treat COVID-19 symptoms- April 28, 2021- An oral drug could be taken at home and might keep people out of the hospital. 
- News- Psoriasis associated with an increased risk of COVID-19 in real-world study- April 28, 2021- Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy. 
- News- CDC: Vaccinated people can mostly drop masks outdoors- April 27, 2021- It is a minor – but still significant – step toward the end of pandemic restrictions. 
![1]() - News- Half of patients in hospital for COVID-19 get acute kidney injury- April 27, 2021- It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening of CKD. 
- News- Infective endocarditis from IV drug use tied to hemorrhagic stroke- April 27, 2021- The incidence of patients with IVDU-associated endocarditis increased 630% from 2014 to 2018. 
![1]() - News- Pediatric bronchiolitis: Less is more- April 27, 2021- With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on supportive care, researchers say. 
![1]() - News- Trend reversed: New cases of COVID-19 decline in children- April 27, 2021- Children’s share of weekly cases continues to rise, setting another pandemic high. 
![1]() - News- Thyroid hormone analogues can reverse NASH- April 27, 2021- In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo? 
![1]() - News- Efficacy and safety of daily low-dose colchicine after recent MI- April 26, 2021- Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo? 




